IPSEN – Buy-back programme – Art 5 of MAR – Week 28 – 2024
IPSEN – Buy-back programme – Art 5 of MAR – Week 28 – 2024
Aggregated presentation by day and by market
| Purchases of own shares from July 8th to 12th 2024 | ||||||
| Name of the Issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 6 650 | 111,0282 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 2 700 | 110,9397 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 350 | 111,1231 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 300 | 111,2180 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 4 900 | 109,7478 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 2 100 | 109,6744 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 5 382 | 108,6341 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 2 000 | 108,7151 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 1 487 | 110,1258 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 299 | 110,1107 | CEUX |
| TOTAL | 26 168 | 109,9431 | ||||
Attachment

IPSEN – Buy-back programme – Art 5 of MAR – Week 28 – 2024
Aggregated presentation by day and by market
| Purchases of own shares from July 8th to 12th 2024 | ||||||
| Name of the Issuer | Identity code of the Issuer | Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 6 650 | 111,0282 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 2 700 | 110,9397 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 350 | 111,1231 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 08/07/2024 | FR0010259150 | 300 | 111,2180 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 4 900 | 109,7478 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 09/07/2024 | FR0010259150 | 2 100 | 109,6744 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 5 382 | 108,6341 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 10/07/2024 | FR0010259150 | 2 000 | 108,7151 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 1 487 | 110,1258 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 11/07/2024 | FR0010259150 | 299 | 110,1107 | CEUX |
| TOTAL | 26 168 | 109,9431 | ||||
Attachment

Related stories
Quand les acides biliaires prennent une dimension plus large : comment la biologie de la cholestase transforme la recherche sur les maladies hépatiques rares
Tester l’hypothèse : un pilote ciblé sur l’IA dans le domaine de la santé
Toujours une longueur d’avance : Anne Petit et l’art de concrétiser les médicaments
Related Press Releases
Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset...
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – June 2026 – Monthly information relative to the...
Ipsen – Half year statement – 2026 06 30
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus...
Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline
IPSEN – Buy-back programme – Art 5 of MAR –...